Documents | Prucalopride for the treatment of chronic constipation in women | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

TA211 Constipation (women) - prucalopride: review decision - January 2014 information
Appendix A: decision paper presented to the Institute's Guidance Executive ^{PDF 126.03 KB} 27 January 2014
TA211 Constipation (women) - prucalopride: review proposal - November 2013 information
Appendix A: provisional matrix of stakeholders ^{PDF 102.79 KB} 04 November 2013
Appendix B: proposal paper presented to the Institute's Guidance Executive ^{PDF 449.07 KB} 04 November 2013
Constipation (women) - prucalopride: press release information
2010/179 NICE recommends prucalopride for chronic constipation in women ^{PDF 81.61 KB} 06 December 2013

Constipation (women) - prucalopride: Equality Impact Assessment form

Constipation (women) - prucalopride: Equality Impact Assessment form ^{PDF 75.12 KB} 15 December 2010

Constipation (women) - prucalopride: final appraisal determination

Constipation (women) - prucalopride: final appraisal determination information
Constipation (women) - prucalopride: final appraisal determination ^{PDF 249.04 KB} 22 October 2010
Constipation (women) - prucalopride: response to consultee, commentator and public comments on the ACD and comments from website consultation ^{PDF 367.5 KB} 22 October 2010
Constipation (women) - prucalopride: consultee and commentator comments on the ACD
Constipation (women) - prucalopride: manufacturer
Constipation (women) - prucalopride: Movetis comments ^{PDF 24.81 KB} 22 October 2010
Constipation (women) - prucalopride: Movetis letter ^{PDF 42.93 KB} 22 October 2010
Constipation (women) - prucalopride: British Society of Gastroenterology and Royal College of Physicians (joint submission) ^{PDF 38.92 KB} 22 October 2010
Constipation (women) - prucalopride: commentators
Constipation (women) - prucalopride: Norgine Pharmaceuticals Ltd comments on cost-effectiveness assessment ^{PDF 252.44 KB} 22 October 2010
Constipation (women) - prucalopride: Norgine Pharmaceuticals Ltd comments on clinical assessment ^{PDF 85.27 KB} 22 October 2010
Constipation (women) - prucalopride: West Midlands Health Technology Assessment Collaboration comments ^{PDF 134.58 KB} 22 October 2010
Constipation (women) - prucalopride: comments on the ACD received from the public through the NICE website
Constipation (women) - prucalopride: web comments ^{PDF 291.42 KB} 22 October 2010
Constipation (women) - prucalopride: public comments 1 ^{PDF 306.7 KB} 22 October 2010
Constipation (women) - prucalopride: public comments 2 ^{PDF 7.26 KB} 22 October 2010

Constipation (women) - prucalopride: press release on the draft guidance consultation

Constipation (women) - prucalopride: appraisal consultation

Constipation (women) - prucalopride: appraisal consultation
Constipation (women) - prucalopride: appraisal consultation document information
Constipation (women) - prucalopride: appraisal consultation: evaluation report
Constipation (women) - prucalopride: pre-meeting briefing ^{PDF 221.12 KB} 03 August 2010
Constipation (women) - prucalopride: evidence review group report ^{PDF 657.05 KB} 03 August 2010
Constipation (women) - prucalopride: manufacturer response to the evidence review group report
Constipation (women) - prucalopride: Movetis letter to accompany response to ERG report ^{PDF 80.75 KB} 03 August 2010
Constipation (women) - prucalopride: Movetis critique of ERG report ^{PDF 174.48 KB} 29 July 2010
Constipation (women) - prucalopride: non-manufacturer submissions
Constipation (women) - prucalopride: PromoCon statement ^{PDF 36.29 KB} 03 August 2010
Constipation (women) - prucalopride: British Society of Gastroenterology statement ^{PDF 45.25 KB} 03 August 2010
Constipation (women) - prucalopride: NHS Greenwich ^{PDF 31.04 KB} 03 August 2010
Constipation (women) - prucalopride: Movetis ^{PDF 5.44 MB} 03 August 2010
Constipation (women) - prucalopride: NICE clarification letter ^{PDF 65.96 KB} 03 August 2010
Constipation (women) - prucalopride: Movetis response to NICE clarification letter ^{PDF 457.8 KB} 03 August 2010
Constipation (women) - prucalopride: expert statements
Constipation (women) - prucalopride: Whorwell ^{PDF 34.16 KB} 03 August 2010
Constipation (women) - prucalopride: Emmanuel ^{PDF 12.76 KB} 03 August 2010
Constipation (women) - prucalopride: Rogers ^{PDF 10.68 KB} 03 August 2010
Constipation (women) - prucalopride: Amin ^{PDF 14.17 KB} 03 August 2010

Constipation (women) - prucalopride: final scope

Constipation (women) - prucalopride: final scope ^{PDF 37.38 KB} 08 February 2010

Constipation (women) - prucalopride: response to consultees and commentators on the draft scope

Constipation (women) - prucalopride: response to consultees and commentators on the draft scope ^{PDF 58.64 KB} 08 February 2010

Constipation (women) - prucalopride: response to consultees and commentators on the provisional matrix

Constipation (women) - prucalopride: response to consultees and commentators on the provisional matrix ^{PDF 22.75 KB} 08 February 2010